paracox-5 suukaudse suspensiooni suspensioon
intervet international b.v. - koktsiidide vaktsiin - suukaudse suspensiooni suspensioon - 1annus 0.004ml 20ml 5tk
paracox-8 vet. suukaudse suspensiooni suspensioon
intervet international b.v. - koktsiidide vaktsiin - suukaudse suspensiooni suspensioon - 1annus 0.004ml 20ml 1tk; 1annus 0.1ml 100ml 1tk; 1annus 0.1ml 500ml 1tk; 1annus 0.004ml 4ml 1tk; 1ml 100ml 1tk
furocef õhukese polümeerikattega tablett
krka d.d. novo mesto - tsefuroksiim - õhukese polümeerikattega tablett - 250mg 14tk; 250mg 10tk; 250mg 15tk; 250mg 8tk; 250mg 20tk; 250mg 12tk; 250mg 24tk; 250mg 16tk
furocef õhukese polümeerikattega tablett
krka d.d. novo mesto - tsefuroksiim - õhukese polümeerikattega tablett - 500mg 8tk; 500mg 20tk; 500mg 24tk; 500mg 16tk; 500mg 15tk; 500mg 10tk
metoprolol accord toimeainet prolongeeritult vabastav tablett
accord healthcare limited - metoprolool - toimeainet prolongeeritult vabastav tablett - 200mg 10tk; 200mg 20tk; 200mg 30tk; 200mg 56tk; 200mg 100tk; 200mg 98tk; 200mg 400tk; 200mg 50tk; 200mg 14tk
bicalutamide kabi 50mg õhukese polümeerikattega tablett
fresenius kabi polska sp. z o.o. - bikalutamiid - õhukese polümeerikattega tablett - 50mg 50tk; 50mg 90tk; 50mg 14tk; 50mg 30tk; 50mg 60tk; 50mg 56tk; 50mg 100tk; 50mg 28tk
metoprolol accord toimeainet prolongeeritult vabastav tablett
accord healthcare limited - metoprolool - toimeainet prolongeeritult vabastav tablett - 100mg 50tk; 100mg 56tk; 100mg 98tk; 100mg 28tk; 100mg 20tk; 100mg 14tk; 100mg 30tk
equest 2% oral gel for horses suukaudne geel
zoetis belgium - moksidektiin - suukaudne geel - 18,92mg 1g 14.8g 1tk; 18,92mg 1g 14.8g 10tk
dasatinib accordpharma
accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
trimmer® 50 sg
adama - vees dispergeeruvad graanulid - tribenuroon-metüül - herbitsiidid